Federal grants to The Wistar Institute of Anatomy and Biology
The Wistar Institute of Anatomy and Biology in Philadelphia, Pennsylvania received $206 million in federal grants from fiscal 2021 to 2025, across 105 awards. Its largest program was Allergy and Infectious Diseases Research, with $60.9 million. In fiscal 2025 it was awarded $39.6 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$206 million
- Awards105
- Awarded in FY 2025$39.6 million
- Largest award$25.8 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 61 | $40.3 million |
| FY 2022 | 63 | $43.2 million |
| FY 2023 | 53 | $43.2 million |
| FY 2024 | 51 | $39.9 million |
| FY 2025 | 48 | $39.6 million |
Programs that fund The Wistar Institute of Anatomy and Biology
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 18 | $60.9 million |
| Cancer Biology Research | 22 | $36.5 million |
| Cancer Centers Support Grants | 3 | $29.2 million |
| Cancer Treatment Research | 8 | $18.5 million |
| Drug Use and Addiction Research Programs | 3 | $8.4 million |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 5 | $7.3 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 3 | $7.1 million |
| Biomedical Research and Research Training | 9 | $6.9 million |
| Cancer Cause and Prevention Research | 3 | $4.8 million |
| Cardiovascular Diseases Research | 3 | $4.4 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 94 | $200 million |
| Department of Defense | 6 | $4.2 million |
| National Science Foundation | 3 | $1.7 million |
| Department of Commerce | 1 | $249,397 |
| Department of Agriculture | 1 | $99,085 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Beat-hiv: delaney collaboratory to cure HIV-1 infection by combination immunotherapy - summary current HIV curative strategies have proven insufficient to eradicate viral reservoirs or prevent viral rebound after antiretroviral therapy (ART) cessation. The unifying hypothesis for the beat-hiv collab | Allergy and Infectious Diseases Research | August 13, 2021 | $25.8 million |
| Consolidated basic cancer research program | Cancer Centers Support Grants | February 26, 2021 | $14.9 million |
| Synthetic dna-launched and adjuvanted env immunogens for HIV - overall summary a protective vaccine for HIV is arguably the most important prevention strategy to end the global HIV pandemic. The RV144 trial demonstrated a correlation between protection and envelope (ENV) specific serum igg antibodie | Allergy and Infectious Diseases Research | December 8, 2022 | $11.3 million |
| Spore in skin cancer - project summary – overall this wistar/upenn skin spore represents a highly successful and longstanding collaboration. Immune checkpoint inhibition has revolutionized melanoma therapy to the point where every high-risk melanoma patient will be treated at some point with these a | Cancer Centers Support Grants | September 3, 2021 | $11.3 million |
| Targeted therapies in melanoma | Cancer Treatment Research | August 18, 2021 | $7.4 million |
| Targeting the epigenetic and metabolic control of ebv-epithelial cancers - overall – project summary the overall aim of this new program project (P01) proposal is to generate highly collaborative and integrated basic and translational research on the urgent, unmet medical need of epithelial cancers | Cancer Biology Research | May 11, 2023 | $7.1 million |
| Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in hiv-infected, art suppressed opioid use disorder patents initiating medication-assisted treatment | Drug Use and Addiction Research Programs | June 23, 2021 | $5.0 million |
| Individualized HIV curative combination strategy against persistent HIV on art - summary we have demonstrated multiple lines of evidence supporting the role for autologous neutralizing antibodies (ANABS) to restrict virus rebound. The positive relationship between anab suppression of virus reactivat | Allergy and Infectious Diseases Research | July 3, 2025 | $3.6 million |
| Structural vaccinology guided development of a universal cov vaccine utilizing nucleic acid delivered nanoparticles - project summary in december 2019 a novel coronavirus, named sudden acute respiratory syndrome CORONAVIRUS-2 (sars-cov- 2). SARS-COV-2 rapidly spread around the globe causing a pandem | Allergy and Infectious Diseases Research | September 22, 2022 | $3.5 million |
| Tumor plasticity | Cancer Biology Research | August 24, 2021 | $3.4 million |
Questions people ask
How much federal grant money does The Wistar Institute of Anatomy and Biology get?
$206 million in 105 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives The Wistar Institute of Anatomy and Biology the most?
The Department of Health and Human Services, with $200 million in 94 awards. The Department of Defense and the National Science Foundation follow.
What is The Wistar Institute of Anatomy and Biology's largest federal grant?
$25.8 million under Allergy and Infectious Diseases Research, with its first action in the period on August 13, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund The Wistar Institute of Anatomy and Biology?
Its largest are Allergy and Infectious Diseases Research, Cancer Biology Research and Cancer Centers Support Grants.
Other grant recipients in Philadelphia
- The Trustees of the University of Pennsylvania
- Southeastern Pennsylvania Transportation Authority
- Opportunity Finance Network
- Pennvest
- Philadelphia Housing Authority
- The Children's Hospital of Philadelphia
- Temple University-of the Commonwealth System of Higher Education
- City of Philadelphia
Largest federal grant recipients in Pennsylvania · Federal grants in Pennsylvania